The Research and Development team at Stablix is dedicated to advancing the science of targeted protein stabilization (TPS) by conducting innovative research and experiments to discover and optimize novel therapeutic solutions. With a diverse group of senior scientists and advisors, the team collaborates to translate cutting-edge scientific insights into new medicines that address critical patient needs. Through rigorous testing and validation, they aim to enhance the efficacy and stability of biologics, ultimately driving forward Stablix's mission to revolutionize patient care.
Adi Minis, PhD
Senior Scientist
Andrew Turnbull
Scientific Advisor
Anna Kaplan
Senior Scientist II
Benedikt Kessler
Scientific Advisor
Benjamin Levin
Principal Scientist
Chris Dinsmore
Scientific Advisor
Henry Colecraft
Co-Founder & Chair, Scientific...
Isabelle Schmutz
Senior Scientist II
Michael Post
Senior Scientist
Tyler Mann
Senior Scientist
View all